Clinical Trial Update: Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low Trial [Phase 3]

View source ↗

Summary

Phase 3 RxFINE-Low trial is evaluating whether hormone therapy with ribociclib is as effective as chemotherapy followed by hormone therapy with ribociclib for h…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Ribociclib (ribociclib)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8 | Phase 3 | Status: NOT_YET_RECRUITING